HTTrack3.49-2+htsswf+htsjava launched on Wed, 18 Dec 2024 02:48:03 at https://bridgebio.com/ +*.png +*.gif +*.jpg +*.jpeg +*.css +*.js -ad.doubleclick.net/* -mime:application/foobar
(winhttrack -qwC2%Ps2u1%s%uN0%I0p3DaK0H0%kf2A25000%f#f -F "Mozilla/4.5 (compatible; HTTrack 3.0x; Windows 98)" -%F "<!-- Mirrored from %s%s by HTTrack Website Copier/3.x [XR&CO'2014], %s -->" -%l "en, *" https://bridgebio.com/ -O1 "C:\Users\HP\Documents\programming\clones\bridge-original" +*.png +*.gif +*.jpg +*.jpeg +*.css +*.js -ad.doubleclick.net/* -mime:application/foobar )

Information, Warnings and Errors reported for this mirror:
note:	the hts-log.txt file, and hts-cache folder, may contain sensitive information,
	such as username/password authentication for websites mirrored in this project
	do not share these files/folders if you want these information to remain private

02:48:34	Error: 	"Bad Request" (400) at link https://www.googletagmanager.com/gtm.js?id= (from https://bridgebio.com/)
02:50:42	Warning: 	Link https://bridgebio.com/cdn-cgi/l/email-protection not scanned (follow robots meta tag)
02:50:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=857
02:50:42	Warning: 	File has moved from https://bridgebio.com/?p=857 to https://bridgebio.com/about-us/
02:50:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=862
02:50:42	Warning: 	File has moved from https://bridgebio.com/?p=862 to https://bridgebio.com/people/
02:50:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=4096
02:50:42	Warning: 	File has moved from https://bridgebio.com/?p=4096 to https://bridgebio.com/partners/
02:50:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=1040
02:50:42	Warning: 	File has moved from https://bridgebio.com/?p=1040 to https://bridgebio.com/careers/
02:53:05	Warning: 	Moved Permanently for https://bridgebio.com/?p=4090
02:53:05	Warning: 	File has moved from https://bridgebio.com/?p=4090 to https://bridgebio.com/pipeline/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=1078
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=1078 to https://bridgebio.com/publications/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/licensing-opportunities/
02:53:20	Warning: 	File has moved from https://bridgebio.com/licensing-opportunities/ to https://bridgebio.com/licensing-opportunities
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=5450
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=5450 to https://bridgebio.com/licensing-opportunities
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=4314
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=4314 to https://bridgebio.com/patients-and-families/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=4623
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=4623 to https://bridgebio.com/patients-and-families/alexis/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=4625
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=4625 to https://bridgebio.com/patients-and-families/elliott/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=2772
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=2772 to https://bridgebio.com/patients-and-families/miguel/
02:53:20	Error: 	"Not Found" (404) at link https://bbio2019.azurewebsites.net/wp-content/uploads/2021/08/ASP_Cnvn_Tobin_0820.jpg (from https://bridgebio.com/patients-and-families/tobin/)
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=4629
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=4629 to https://bridgebio.com/patients-and-families/tobin/
02:53:20	Warning: 	Moved Permanently for https://bridgebio.com/?p=869
02:53:20	Warning: 	File has moved from https://bridgebio.com/?p=869 to https://bridgebio.com/news/
02:56:06	Warning: 	Moved Permanently for https://bridgebio.com/?p=4627
02:56:06	Warning: 	File has moved from https://bridgebio.com/?p=4627 to https://bridgebio.com/patients-and-families/len/
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789+/ (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/jquery.build.js (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/jquery.js (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/comparators.js (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/fields/fieldhelpers.js (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Error: 	"Not Found" (404) at link https://bridgebio.com/fieldHelpers.js (from pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:56:07	Warning: 	Moved Permanently for https://bridgebio.com/?p=1067
02:56:07	Warning: 	File has moved from https://bridgebio.com/?p=1067 to https://bridgebio.com/terms-of-use/
02:56:07	Warning: 	Moved Permanently for https://bridgebio.com/?p=3275
02:56:07	Warning: 	File has moved from https://bridgebio.com/?p=3275 to https://bridgebio.com/bridgebio-global-privacy-policy/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=3841
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=3841 to https://bridgebio.com/cookies-notice/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6644
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6644 to https://bridgebio.com/us-expanded-access-policy/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6654
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6654 to https://bridgebio.com/contact-us/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6886
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6886 to https://bridgebio.com/sms-policy/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/social-policy/
02:56:12	Warning: 	File has moved from https://bridgebio.com/social-policy/ to https://bridgebio.com/social-policy
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7107
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7107 to https://bridgebio.com/social-policy
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7130
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7130 to https://bridgebio.com/careers/manager-revenue/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7101
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7101 to https://bridgebio.com/careers/associate-director-biostatistics/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6808
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6808 to https://bridgebio.com/careers/director-biostatistics/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6762
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6762 to https://bridgebio.com/careers/associate-director-director-business-development-and-operations/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7103
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7103 to https://bridgebio.com/careers/associate-director-commercial-strategy-operations/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6946
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6946 to https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6828
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6828 to https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7131
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7131 to https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7132
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7132 to https://bridgebio.com/careers/director-biology-and-translational-research/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6996
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6996 to https://bridgebio.com/careers/director-sr-director-business-development-operations/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7136
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7136 to https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7072
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7072 to https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7061
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7061 to https://bridgebio.com/careers/associate-director-marketing-2/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6804
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6804 to https://bridgebio.com/careers/associate-director-marketing/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6854
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6854 to https://bridgebio.com/careers/director-kol-management-engagement-east/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6903
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6903 to https://bridgebio.com/careers/manager-digital-marketing/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6995
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6995 to https://bridgebio.com/careers/manager-sr-manager-commercial-training/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6861
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6861 to https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7133
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7133 to https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7138
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7138 to https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=7129
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=7129 to https://bridgebio.com/careers/director-clinical-quality-assurance/
02:56:12	Warning: 	Moved Permanently for https://bridgebio.com/?p=6844
02:56:12	Warning: 	File has moved from https://bridgebio.com/?p=6844 to https://bridgebio.com/careers/sr-director-quality-assurance/
02:56:13	Warning: 	Moved Permanently for https://bridgebio.com/?p=6465
02:56:13	Warning: 	File has moved from https://bridgebio.com/?p=6465 to https://bridgebio.com/careers/sr-director-quality-assurance-cmc/
02:56:13	Warning: 	Moved Permanently for https://bridgebio.com/?p=6803
02:56:13	Warning: 	File has moved from https://bridgebio.com/?p=6803 to https://bridgebio.com/careers/director-sr-director-regulatory-affairs/
02:56:13	Warning: 	Moved Permanently for https://bridgebio.com/?p=7091
02:56:13	Warning: 	File has moved from https://bridgebio.com/?p=7091 to https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/
02:56:13	Warning: 	Retry after error -4 (No data (connection closed)) at link https://bridgebio.com/?p=6812 (from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:56:13	Warning: 	Moved Permanently for https://bridgebio.com/?p=7137
02:56:13	Warning: 	File has moved from https://bridgebio.com/?p=7137 to https://bridgebio.com/careers/executive-assistant-sales/
02:56:13	Warning: 	Moved Permanently for https://bridgebio.com/?p=6118
02:56:13	Warning: 	File has moved from https://bridgebio.com/?p=6118 to https://bridgebio.com/what-is-adh1/
02:56:52	Warning: 	Moved Permanently for bridgebio.com/adh1/
02:56:52	Warning: 	Redirected link is identical because of 'URL Hack' option: bridgebio.com/adh1/ and https://bridgebio.com/adh1/
02:56:52	Warning: 	File has moved from bridgebio.com/adh1/ to https://bridgebio.com/adh1/
02:56:52	Warning: 	Moved Permanently for https://bridgebio.com/?p=6774
02:56:52	Warning: 	File has moved from https://bridgebio.com/?p=6774 to https://bridgebio.com/lgmd2i-r9/
02:57:17	Warning: 	Moved Permanently for bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/
02:57:17	Warning: 	Redirected link is identical because of 'URL Hack' option: bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/ and https://bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/
02:57:17	Warning: 	File has moved from bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/ to https://bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/
02:57:17	Error: 	"Not Found" (404) at link https://bridgebio.com/news/7135-2/feed/ (from https://bridgebio.com/news/7135-2/)
02:57:17	Warning: 	Moved Permanently for https://bridgebio.com/?p=7135
02:57:17	Warning: 	File has moved from https://bridgebio.com/?p=7135 to https://bridgebio.com/news/7135-2/
02:57:17	Error: 	"Not Found" (404) at link https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-≥90-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/feed/ (from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-≥90-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:57:17	Warning: 	Moved Permanently for https://bridgebio.com/?p=7123
02:57:17	Warning: 	File has moved from https://bridgebio.com/?p=7123 to https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/
02:57:17	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=7121
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=7121 to https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/feed/ (from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6842
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6842 to https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/feed/ (from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6826
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6826 to https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/feed/ (from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6815
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6815 to https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/feed/ (from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6819
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6819 to https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/feed/ (from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6801
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6801 to https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/feed/ (from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6767
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6767 to https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6766
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6766 to https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:57:18	Warning: 	Moved Permanently for https://bridgebio.com/?p=6761
02:57:18	Warning: 	File has moved from https://bridgebio.com/?p=6761 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/
02:57:18	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/feed/ (from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6753
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6753 to https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/feed/ (from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6751
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6751 to https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6749
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6749 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/feed/ (from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6739
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6739 to https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6730
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6730 to https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6711
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6711 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6672
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6672 to https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/feed/ (from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6639
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6639 to https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/
02:57:19	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:57:19	Warning: 	Moved Permanently for https://bridgebio.com/?p=6615
02:57:19	Warning: 	File has moved from https://bridgebio.com/?p=6615 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/
02:57:55	Warning: 	Moved Permanently for https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36/
02:57:55	Warning: 	File has moved from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36/ to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/
02:58:53	Warning: 	Moved Permanently for https://bridgebio.com/news/aha-data-placeholder/
02:58:53	Warning: 	File has moved from https://bridgebio.com/news/aha-data-placeholder/ to https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha
03:09:21	Warning: 	Moved Permanently for https://bridgebio.com/?p=3419
03:09:21	Warning: 	File has moved from https://bridgebio.com/?p=3419 to https://bridgebio.com/news/archive/
03:09:30	Warning: 	Moved Permanently for https://bridgebio.com/bridgebio-hcp-privacy-notice/
03:09:30	Warning: 	File has moved from https://bridgebio.com/bridgebio-hcp-privacy-notice/ to https://bridgebio.com/bridgebio-hcp-privacy-notice
03:09:30	Warning: 	Moved Permanently for https://bridgebio.com/?p=5775
03:09:30	Warning: 	File has moved from https://bridgebio.com/?p=5775 to https://bridgebio.com/bridgebio-hcp-privacy-notice
03:09:30	Warning: 	Moved Permanently for https://bridgebio.com/?p=5776
03:09:30	Warning: 	File has moved from https://bridgebio.com/?p=5776 to https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/
03:09:30	Warning: 	Moved Permanently for https://bridgebio.com/?p=6812
03:09:30	Warning: 	File has moved from https://bridgebio.com/?p=6812 to https://bridgebio.com/careers/vp-regulatory-affairs/
03:09:30	Warning: 	Moved Permanently for https://bridgebio.com/?p=6250
03:09:30	Warning: 	File has moved from https://bridgebio.com/?p=6250 to https://bridgebio.com/what-is-adh1/encaleret/
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=6331
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=6331 to https://bridgebio.com/what-is-adh1/patient-resources/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=6106
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=6106 to https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/feed/ (from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=5797
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=5797 to https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/feed/ (from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=5529
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=5529 to https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=5517
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=5517 to https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=5202
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=5202 to https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/feed/ (from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=3834
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=3834 to https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=3486
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=3486 to https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=3302
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=3302 to https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/
03:09:31	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
03:09:31	Warning: 	Moved Permanently for https://bridgebio.com/?p=4118
03:09:31	Warning: 	File has moved from https://bridgebio.com/?p=4118 to https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6799
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6799 to https://bridgebio.com/lgmd2i-r9/bbp-418/
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6797
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6797 to https://bridgebio.com/lgmd2i-r9/patient-resources/
03:09:32	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6574
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6574 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/
03:09:32	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6549
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6549 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/
03:09:32	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6545
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6545 to https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/
03:09:32	Error: 	"Not Found" (404) at link https://bridgebio.com/news/achondroplasia-investor-call/feed/ (from https://bridgebio.com/news/achondroplasia-investor-call/)
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6544
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6544 to https://bridgebio.com/news/achondroplasia-investor-call/
03:09:32	Error: 	"Not Found" (404) at link https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/feed/ (from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
03:09:32	Warning: 	Moved Permanently for https://bridgebio.com/?p=6532
03:09:32	Warning: 	File has moved from https://bridgebio.com/?p=6532 to https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/
03:09:34	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
03:09:34	Warning: 	Moved Permanently for https://bridgebio.com/?p=6521
03:09:34	Warning: 	File has moved from https://bridgebio.com/?p=6521 to https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6509
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6509 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6507
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6507 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6500
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6500 to https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/
03:09:35	Error: 	"Not Found" (404) at link bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_1.png (from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6472
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6472 to https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/
03:09:35	Error: 	"Not Found" (404) at link bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_2.png (from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/feed/ (from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6473
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6473 to https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6407
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6407 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/
03:09:35	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
03:09:35	Warning: 	Moved Permanently for https://bridgebio.com/?p=6405
03:09:35	Warning: 	File has moved from https://bridgebio.com/?p=6405 to https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6379
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6379 to https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6373
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6373 to https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6369
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6369 to https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6343
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6343 to https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6285
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6285 to https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6282
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6282 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6281
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6281 to https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/feed/ (from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6277
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6277 to https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/feed/ (from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6259
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6259 to https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/nejm-pr-post/feed/ (from https://bridgebio.com/news/nejm-pr-post/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6240
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6240 to https://bridgebio.com/news/nejm-pr-post/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6241
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6241 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6166
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6166 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/feed/ (from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6168
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6168 to https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6148
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6148 to https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6149
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6149 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6146
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6146 to https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6134
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6134 to https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6131
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6131 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6119
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6119 to https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
03:09:38	Warning: 	Moved Permanently for https://bridgebio.com/?p=6107
03:09:38	Warning: 	File has moved from https://bridgebio.com/?p=6107 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/
03:09:38	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-⍺dg-levels-as-a-surrogate-endpoint-in-limb-g/feed/ (from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-⍺dg-levels-as-a-surrogate-endpoint-in-limb-g/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6101
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6101 to https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/feed/ (from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6098
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6098 to https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6096
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6096 to https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6084
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6084 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6078
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6078 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6081
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6081 to https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/feed/ (from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6068
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6068 to https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=6066
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=6066 to https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5977
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5977 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5968
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5968 to https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-⍺dg-levels-and-announ/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-⍺dg-levels-and-announ/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5964
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5964 to https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5956
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5956 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/ (from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5958
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5958 to https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/feed/ (from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5954
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5954 to https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/feed/ (from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5951
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5951 to https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5945
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5945 to https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5938
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5938 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5935
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5935 to https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5881
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5881 to https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5877
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5877 to https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5875
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5875 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5873
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5873 to https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5870
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5870 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5866
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5866 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5861
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5861 to https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/
03:09:39	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-⍺dg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-⍺dg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:39	Warning: 	Moved Permanently for https://bridgebio.com/?p=5860
03:09:39	Warning: 	File has moved from https://bridgebio.com/?p=5860 to https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-⍺dg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-⍺dg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5854
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5854 to https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5850
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5850 to https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5847
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5847 to https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5841
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5841 to https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/feed/ (from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5842
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5842 to https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5832
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5832 to https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5826
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5826 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5823
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5823 to https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5820
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5820 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5801
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5801 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5771
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5771 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5769
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5769 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3kαras-breaker-mechanism-at-the-fourth-ras-initiative/feed/ (from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3kαras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5767
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5767 to https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5766
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5766 to https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5765
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5765 to https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5761
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5761 to https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5759
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5759 to https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5755
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5755 to https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5751
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5751 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5748
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5748 to https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5743
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5743 to https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5713
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5713 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/5706-2/feed/ (from https://bridgebio.com/news/5706-2/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5706
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5706 to https://bridgebio.com/news/5706-2/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5705
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5705 to https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5702
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5702 to https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5701
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5701 to https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5696
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5696 to https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5541
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5541 to https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/feed/ (from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5522
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5522 to https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5497
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5497 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5486
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5486 to https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/feed/ (from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5484
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5484 to https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/5481-2/feed/ (from https://bridgebio.com/news/5481-2/)
03:09:40	Warning: 	Moved Permanently for https://bridgebio.com/?p=5481
03:09:40	Warning: 	File has moved from https://bridgebio.com/?p=5481 to https://bridgebio.com/news/5481-2/
03:09:40	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/feed/ (from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5479
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5479 to https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/feed/ (from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5468
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5468 to https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5456
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5456 to https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5464
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5464 to https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/ (from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5407
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5407 to https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5404
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5404 to https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5373
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5373 to https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5362
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5362 to https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5353
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5353 to https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/feed/ (from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5346
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5346 to https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5343
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5343 to https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5257
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5257 to https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/feed/ (from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5256
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5256 to https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5249
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5249 to https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5248
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5248 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5234
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5234 to https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5233
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5233 to https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5232
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5232 to https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5228
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5228 to https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5224
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5224 to https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:09:41	Warning: 	Moved Permanently for https://bridgebio.com/?p=5220
03:09:41	Warning: 	File has moved from https://bridgebio.com/?p=5220 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/
03:09:41	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5217
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5217 to https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/
03:09:42	Warning: 	Moved Permanently for bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants
03:09:42	Warning: 	Redirected link is identical because of 'URL Hack' option: bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants and https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants
03:09:42	Warning: 	File has moved from bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants to https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5214
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5214 to https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5211
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5211 to https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/feed/ (from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5199
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5199 to https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5195
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5195 to https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=5192
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=5192 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=4876
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=4876 to https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:09:42	Warning: 	Moved Permanently for https://bridgebio.com/?p=4875
03:09:42	Warning: 	File has moved from https://bridgebio.com/?p=4875 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/
03:09:42	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=4874
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=4874 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=4873
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=4873 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/feed/ (from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=4960
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=4960 to https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3872
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3872 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3863
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3863 to https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3844
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3844 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3823
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3823 to https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3800
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3800 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/feed/ (from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3793
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3793 to https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3751
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3751 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3646
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3646 to https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3643
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3643 to https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3640
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3640 to https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3637
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3637 to https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3634
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3634 to https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3629
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3629 to https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3626
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3626 to https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3600
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3600 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3519
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3519 to https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3390
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3390 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3364
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3364 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3317
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3317 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/
03:09:43	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:43	Warning: 	Moved Permanently for https://bridgebio.com/?p=3282
03:09:43	Warning: 	File has moved from https://bridgebio.com/?p=3282 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3244
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3244 to https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3236
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3236 to https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3219
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3219 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3183
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3183 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3168
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3168 to https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3171
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3171 to https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3164
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3164 to https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/feed/ (from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3154
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3154 to https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3141
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3141 to https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:09:44	Warning: 	Moved Permanently for https://bridgebio.com/?p=3118
03:09:44	Warning: 	File has moved from https://bridgebio.com/?p=3118 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/
03:09:44	Error: 	"Not Found" (404) at link https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/feed/ (from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=3106
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=3106 to https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/feed/ (from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=3099
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=3099 to https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=3061
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=3061 to https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=3057
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=3057 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=3039
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=3039 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2930
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2930 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2898
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2898 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2892
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2892 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2879
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2879 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2852
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2852 to https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/feed/ (from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2855
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2855 to https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2792
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2792 to https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=4120
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=4120 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2774
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2774 to https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=4119
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=4119 to https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/feed/ (from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:09:45	Warning: 	Moved Permanently for https://bridgebio.com/?p=2761
03:09:45	Warning: 	File has moved from https://bridgebio.com/?p=2761 to https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/
03:09:45	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2748
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2748 to https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2733
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2733 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2846
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2846 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2659
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2659 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2614
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2614 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/feed/ (from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2594
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2594 to https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/feed/ (from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2564
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2564 to https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2543
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2543 to https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2523
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2523 to https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2519
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2519 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2479
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2479 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2455
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2455 to https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2450
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2450 to https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2422
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2422 to https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2412
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2412 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2373
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2373 to https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2278
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2278 to https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2270
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2270 to https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2227
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2227 to https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2218
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2218 to https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2210
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2210 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/feed/ (from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2093
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2093 to https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2074
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2074 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/feed/ (from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2059
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2059 to https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2029
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2029 to https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2012
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2012 to https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=2009
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=2009 to https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1996
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1996 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1991
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1991 to https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1963
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1963 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/feed/ (from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1957
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1957 to https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1909
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1909 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/feed/ (from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1760
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1760 to https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1755
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1755 to https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/feed/ (from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1751
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1751 to https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1746
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1746 to https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/
03:09:46	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:09:46	Warning: 	Moved Permanently for https://bridgebio.com/?p=1732
03:09:46	Warning: 	File has moved from https://bridgebio.com/?p=1732 to https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1720
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1720 to https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1713
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1713 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/feed/ (from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1703
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1703 to https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1700
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1700 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1681
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1681 to https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/feed/ (from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1678
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1678 to https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1672
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1672 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1639
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1639 to https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/feed/ (from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1598
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1598 to https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/feed/ (from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1552
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1552 to https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/feed/ (from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1527
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1527 to https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/feed/ (from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1509
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1509 to https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/feed/ (from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1477
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1477 to https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/feed/ (from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1455
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1455 to https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/feed/ (from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1449
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1449 to https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1365
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1365 to https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/feed/ (from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1323
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1323 to https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/feed/ (from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1179
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1179 to https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/
03:09:47	Error: 	"Not Found" (404) at link https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/feed/ (from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:09:47	Warning: 	Moved Permanently for https://bridgebio.com/?p=1007
03:09:47	Warning: 	File has moved from https://bridgebio.com/?p=1007 to https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/feed/ (from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=838
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=838 to https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/feed/ (from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=206
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=206 to https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/feed/ (from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=69
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=69 to https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/feed/ (from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=166
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=166 to https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/feed/ (from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=146
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=146 to https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/feed/ (from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=70
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=70 to https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/feed/ (from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=81
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=81 to https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/
03:09:49	Error: 	"Not Found" (404) at link https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/feed/ (from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:09:49	Warning: 	Moved Permanently for https://bridgebio.com/?p=163
03:09:49	Warning: 	File has moved from https://bridgebio.com/?p=163 to https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/feed/ (from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=207
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=207 to https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/feed/ (from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=167
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=167 to https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/feed/ (from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=82
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=82 to https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/feed/ (from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=83
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=83 to https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/feed/ (from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=84
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=84 to https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/feed/ (from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=85
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=85 to https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/feed/ (from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=125
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=125 to https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/feed/ (from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=126
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=126 to https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/feed/ (from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=165
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=165 to https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/feed/ (from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=164
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=164 to https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/feed/ (from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=67
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=67 to https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/feed/ (from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=162
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=162 to https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/feed/ (from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=127
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=127 to https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/feed/ (from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=128
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=128 to https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/feed/ (from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=129
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=129 to https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/feed/ (from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=145
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=145 to https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/feed/ (from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=66
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=66 to https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/feed/ (from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=203
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=203 to https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/feed/ (from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=148
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=148 to https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/feed/ (from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=205
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=205 to https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/feed/ (from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=149
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=149 to https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/feed/ (from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=147
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=147 to https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/feed/ (from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=68
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=68 to https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/feed/ (from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=202
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=202 to https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/feed/ (from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=131
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=131 to https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/feed/ (from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=144
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=144 to https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/
03:09:50	Error: 	"Not Found" (404) at link https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/feed/ (from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:50	Warning: 	Moved Permanently for https://bridgebio.com/?p=204
03:09:50	Warning: 	File has moved from https://bridgebio.com/?p=204 to https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/
03:09:51	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha/feed/ (from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:51	Warning: 	Moved Permanently for https://bridgebio.com/?p=6135
03:09:51	Warning: 	File has moved from https://bridgebio.com/?p=6135 to https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha?p=6135
03:09:52	Error: 	"Not Found" (404) at link https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/feed/ (from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:52	Warning: 	Moved Permanently for https://bridgebio.com/?p=6389
03:09:52	Warning: 	File has moved from https://bridgebio.com/?p=6389 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/?p=6389
03:09:53	Warning: 	Moved Permanently for https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/?p=6389
03:09:53	Warning: 	File has moved from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/?p=6389 to https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/

HTTrack Website Copier/3.49-2 mirror complete in 21 minutes 50 seconds : 2599 links scanned, 1936 files written (203974447 bytes overall) [179020886 bytes received at 136657 bytes/sec], 50564032 bytes transferred using HTTP compression in 2031 files, ratio 26%, 67.8 requests per connection
(302 errors, 721 warnings, 0 messages)
